9-(2-hydroxy-3-nonyl)adenine has been researched along with Aging in 4 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"Adenosine is an ubiquitously occurring endogenous nucleoside that via cell surface receptors exerts multiple antihypertensive actions, and mediates a number of biological responses that may reduce cardiovascular disease risk." | 1.30 | Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats. ( Jackson, EK; Kusaka, H; Li, P; Tofovic, SP, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenton, RA | 1 |
Dobson, JG | 1 |
Pazzagli, M | 1 |
Corsi, C | 1 |
Fratti, S | 1 |
Pedata, F | 1 |
Pepeu, G | 1 |
Tofovic, SP | 1 |
Kusaka, H | 1 |
Li, P | 1 |
Jackson, EK | 1 |
Hinschen, AK | 1 |
Rose'Meyer, RB | 1 |
Headrick, JP | 1 |
4 other studies available for 9-(2-hydroxy-3-nonyl)adenine and Aging
Article | Year |
---|---|
Reduced adenosine release from the aged mammalian heart.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adrenergic Antagonists; Agi | 2012 |
Regulation of extracellular adenosine levels in the striatum of aging rats.
Topics: 2-Amino-5-phosphonovalerate; Adenine; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; A | 1995 |
Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Aging; Animals; Blood Pressure; Enzyme Inhibitor | 1998 |
Age-related changes in A(1)-adenosine receptor-mediated bradycardia.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Aging; Animals; Bradycardia; Enzyme Inhibitors; | 2000 |